NORWALK, Conn., Jan. 23, 2008 (PRIME NEWSWIRE) -- The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded a $1.5 million grant to Serenex, Inc. and $1 million grants to Acceleron Pharma, Inc. and MannKind Corporation through its 2007 Biotech Investment Awards program, a multi-year, results-driven commitment to fund the development of innovative and effective treatments. Based on the achievement of clearly-defined milestones, the MMRF will commit up to $8.8 million over the next three years to this program.
